Compare $CARL vs $SGHT | Chartloom

Compare

$CARL vs $SGHT

Carlsmed Inc · Sight Sciences Inc

CARL

Carlsmed Inc

SGHT

Sight Sciences Inc

Compare $CARL vs $SGHT

Comparing Carlsmed Inc and Sight Sciences Inc

CARLCarlsmed Inc

SGHTSight Sciences Inc

CARLCarlsmed Inc

Market cap

$392M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.18x

Rev growth (TTM)

16.1%

YTD performance

24.0%

52W performance

4.3%

FCF yield

-9.1%

SGHTSight Sciences Inc

Market cap

$484M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.94x

Rev growth (TTM)

9.3%

YTD performance

18.9%

52W performance

156.2%

FCF yield

-4.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CARL

SGHT

Detailed metrics comparison

CARL

Carlsmed Inc

SGHT

Sight Sciences Inc

Market Cap

CARL$392M

SGHT$484M

Enterprise Value

CARL$361M

SGHT$445M

Price

CARL$14.42

SGHT$8.89

P/E Ratio

CARLN/A

SGHTN/A

P/S Ratio

CARL6.19x

SGHT5.80x

EV/Sales

CARL5.70x

SGHT5.33x

EV/EBITDA

CARL0.00x

SGHT0.00x

P/B Ratio

CARL4.62x

SGHT8.88x

P/FCF Ratio

CARLN/A

SGHTN/A

EV/FCF

CARL-10.12x

SGHT-18.81x

PEG Ratio

CARLN/A

SGHTN/A

Forward P/E (NTM)

CARLN/A

SGHTN/A

Forward P/S (NTM)

CARL4.18x

SGHT4.94x

Revenue (TTM)

CARL$63M

SGHT$83M

Revenue Growth (YoY)

CARL16.1%

SGHT9.3%

Forward Rev Growth

CARL40.9%

SGHT11.9%

Gross Margin (TTM)

CARL76.6%

SGHT88.4%

Operating Margin (TTM)

CARL0.0%

SGHT0.0%

EBITDA Margin (TTM)

CARL-60.4%

SGHT-32.5%

Net Margin (TTM)

CARL-57.4%

SGHT-35.7%

FCF Margin (TTM)

CARL-56.4%

SGHT-28.4%

Net Income (TTM)

CARL$-36M

SGHT$-30M

FCF (TTM)

CARL$-36M

SGHT$-24M

EPS (TTM)

CARL-$1.34

SGHT-$0.55

ROE (TTM)

CARL-3806.0%

SGHT-5064.0%

ROA (TTM)

CARL-2896.0%

SGHT-2668.0%

ROIC (TTM)

CARL-3278.0%

SGHT-3000.0%

Cash

CARL$46M

SGHT$80M

Debt

CARL$15M

SGHT$41M

Net Cash/Debt

CARL$31M

SGHT$39M

Current Ratio (TTM)

CARL8.84x

SGHT4.95x

Quick Ratio (TTM)

CARL8.32x

SGHT4.45x

Debt/Equity (TTM)

CARL0.18x

SGHT0.77x

Debt/Assets (TTM)

CARL0.0%

SGHT0.0%

Interest Coverage (TTM)

CARLN/A

SGHTN/A

Net Debt/EBITDA (TTM)

CARL0.00x

SGHT0.00x

Beta

CARL2.13

SGHT2.45

52W Performance

CARL4.3%

SGHT156.2%

YTD Performance

CARL24.0%

SGHT18.9%

% from 52W High

CARL-16.3%

SGHT-8.5%

% from 52W Low

CARL69.6%

SGHT178.7%

Asset Turnover (TTM)

CARL0.50x

SGHT0.75x

FCF Yield (TTM)

CARL-9.1%

SGHT-4.9%

Earnings Yield (TTM)

CARL-9.3%

SGHT-6.2%

Dividend Yield (TTM)

CARLN/A

SGHTN/A

Rule of 40

CARL-40.3

SGHT-19.1

EV/GP/RG

CARL0.14

SGHT0.34

Ticker research

View CARL research View SGHT research

Metric	CARL Carlsmed Inc	SGHT Sight Sciences Inc
Market & Valuation
Market Cap	$392M	$484M
Enterprise Value	$361M	$445M
Price	$14.42	$8.89
P/E Ratio	N/A	N/A
P/S Ratio	6.19x	5.80x
EV/Sales	5.70x	5.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.62x	8.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.12x	-18.81x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	4.94x
Revenue & Growth
Revenue (TTM)	$63M	$83M
Revenue Growth (YoY)	16.1%	9.3%
Forward Rev Growth	40.9%	11.9%
Profitability
Gross Margin (TTM)	76.6%	88.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-60.4%	-32.5%
Net Margin (TTM)	-57.4%	-35.7%
FCF Margin (TTM)	-56.4%	-28.4%
Net Income (TTM)	$-36M	$-30M
FCF (TTM)	$-36M	$-24M
EPS (TTM)	-$1.34	-$0.55
ROE (TTM)	-3806.0%	-5064.0%
ROA (TTM)	-2896.0%	-2668.0%
ROIC (TTM)	-3278.0%	-3000.0%
Financial Health
Cash	$46M	$80M
Debt	$15M	$41M
Net Cash/Debt	$31M	$39M
Current Ratio (TTM)	8.84x	4.95x
Quick Ratio (TTM)	8.32x	4.45x
Debt/Equity (TTM)	0.18x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.13	2.45
52W Performance	4.3%	156.2%
YTD Performance	24.0%	18.9%
% from 52W High	-16.3%	-8.5%
% from 52W Low	69.6%	178.7%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.75x
FCF Yield (TTM)	-9.1%	-4.9%
Earnings Yield (TTM)	-9.3%	-6.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-40.3	-19.1
EV/GP/RG	0.14	0.34
Ticker research	View CARL research	View SGHT research

Valuation

P/S Ratio

SGHT

5.80x

CARL

6.19x

EV/FCF

SGHT

-18.81x

CARL

-10.12x

Growth & revenue

Revenue Growth TTM

CARL

16.1%

SGHT

9.3%

Forward Revenue Growth

CARL

40.9%

SGHT

11.9%

Profitability & performance

Gross Margin

SGHT

88.4%

CARL

76.6%

ROE

CARL

-3806.0%

SGHT

-5064.0%

FCF Yield %

SGHT

-4.9%

CARL

-9.1%

52-Week Performance

SGHT

156.2%

CARL

4.3%

Detailed metrics comparison

CARL

Carlsmed Inc

SGHT

Sight Sciences Inc

Market Cap

CARL$392M

SGHT$484M

Enterprise Value

CARL$361M

SGHT$445M

Price

CARL$14.42

SGHT$8.89

P/E Ratio

CARLN/A

SGHTN/A

P/S Ratio

CARL6.19x

SGHT5.80x

EV/Sales

CARL5.70x

SGHT5.33x

EV/EBITDA

CARL0.00x

SGHT0.00x

P/B Ratio

CARL4.62x

SGHT8.88x

P/FCF Ratio

CARLN/A

SGHTN/A

EV/FCF

CARL-10.12x

SGHT-18.81x

PEG Ratio

CARLN/A

SGHTN/A

Forward P/E (NTM)

CARLN/A

SGHTN/A

Forward P/S (NTM)

CARL4.18x

SGHT4.94x

Revenue (TTM)

CARL$63M

SGHT$83M

Revenue Growth (YoY)

CARL16.1%

SGHT9.3%

Forward Rev Growth

CARL40.9%

SGHT11.9%

Gross Margin (TTM)

CARL76.6%

SGHT88.4%

Operating Margin (TTM)

CARL0.0%

SGHT0.0%

EBITDA Margin (TTM)

CARL-60.4%

SGHT-32.5%

Net Margin (TTM)

CARL-57.4%

SGHT-35.7%

FCF Margin (TTM)

CARL-56.4%

SGHT-28.4%

Net Income (TTM)

CARL$-36M

SGHT$-30M

FCF (TTM)

CARL$-36M

SGHT$-24M

EPS (TTM)

CARL-$1.34

SGHT-$0.55

ROE (TTM)

CARL-3806.0%

SGHT-5064.0%

ROA (TTM)

CARL-2896.0%

SGHT-2668.0%

ROIC (TTM)

CARL-3278.0%

SGHT-3000.0%

Cash

CARL$46M

SGHT$80M

Debt

CARL$15M

SGHT$41M

Net Cash/Debt

CARL$31M

SGHT$39M

Current Ratio (TTM)

CARL8.84x

SGHT4.95x

Quick Ratio (TTM)

CARL8.32x

SGHT4.45x

Debt/Equity (TTM)

CARL0.18x

SGHT0.77x

Debt/Assets (TTM)

CARL0.0%

SGHT0.0%

Interest Coverage (TTM)

CARLN/A

SGHTN/A

Net Debt/EBITDA (TTM)

CARL0.00x

SGHT0.00x

Beta

CARL2.13

SGHT2.45

52W Performance

CARL4.3%

SGHT156.2%

YTD Performance

CARL24.0%

SGHT18.9%

% from 52W High

CARL-16.3%

SGHT-8.5%

% from 52W Low

CARL69.6%

SGHT178.7%

Asset Turnover (TTM)

CARL0.50x

SGHT0.75x

FCF Yield (TTM)

CARL-9.1%

SGHT-4.9%

Earnings Yield (TTM)

CARL-9.3%

SGHT-6.2%

Dividend Yield (TTM)

CARLN/A

SGHTN/A

Rule of 40

CARL-40.3

SGHT-19.1

EV/GP/RG

CARL0.14

SGHT0.34

Ticker research

View CARL research View SGHT research

Metric	CARL Carlsmed Inc	SGHT Sight Sciences Inc
Market & Valuation
Market Cap	$392M	$484M
Enterprise Value	$361M	$445M
Price	$14.42	$8.89
P/E Ratio	N/A	N/A
P/S Ratio	6.19x	5.80x
EV/Sales	5.70x	5.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.62x	8.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.12x	-18.81x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	4.94x
Revenue & Growth
Revenue (TTM)	$63M	$83M
Revenue Growth (YoY)	16.1%	9.3%
Forward Rev Growth	40.9%	11.9%
Profitability
Gross Margin (TTM)	76.6%	88.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-60.4%	-32.5%
Net Margin (TTM)	-57.4%	-35.7%
FCF Margin (TTM)	-56.4%	-28.4%
Net Income (TTM)	$-36M	$-30M
FCF (TTM)	$-36M	$-24M
EPS (TTM)	-$1.34	-$0.55
ROE (TTM)	-3806.0%	-5064.0%
ROA (TTM)	-2896.0%	-2668.0%
ROIC (TTM)	-3278.0%	-3000.0%
Financial Health
Cash	$46M	$80M
Debt	$15M	$41M
Net Cash/Debt	$31M	$39M
Current Ratio (TTM)	8.84x	4.95x
Quick Ratio (TTM)	8.32x	4.45x
Debt/Equity (TTM)	0.18x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.13	2.45
52W Performance	4.3%	156.2%
YTD Performance	24.0%	18.9%
% from 52W High	-16.3%	-8.5%
% from 52W Low	69.6%	178.7%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.75x
FCF Yield (TTM)	-9.1%	-4.9%
Earnings Yield (TTM)	-9.3%	-6.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-40.3	-19.1
EV/GP/RG	0.14	0.34
Ticker research	View CARL research	View SGHT research